Related Experiment Videos
Multiple imputation for early stopping of a complex clinical trial
1Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA. betensky@hsph.harvard.edu
Biometrics
|April 17, 1998
Summary
This study introduces a novel method for early clinical trial stopping. By treating trial outcome projection as a missing data problem solved with multiple imputation, it simplifies early stopping decisions when treatment effects are uncertain.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Statistical Inference
Background:
- Early stopping of clinical trials is crucial when no treatment effect is evident.
- Existing conditional and predictive power procedures have limitations in complex scenarios.
- Accurate methods are needed to assess the probability of trial success with interim data.
Purpose of the Study:
- To propose a new statistical method for early clinical trial termination.
- To address limitations of current conditional power approaches in complex clinical trial settings.
- To provide a practical alternative for projecting trial outcomes using interim data.
Main Methods:
- The proposed method frames projecting future trial outcomes as a missing data problem.
- Multiple imputation is employed to complete the "missing" future data.
- This approach bypasses the need for explicit conditional power calculations.
- The method was validated on AIDS Clinical Trials Group (ACTG) protocol 118 and simulated trials.
Main Results:
- The multiple imputation technique effectively projects clinical trial outcomes.
- This method simplifies the process of determining early stopping points.
- It offers a viable alternative to complex conditional power calculations in practice.
Conclusions:
- Multiple imputation provides a robust framework for early clinical trial stopping decisions.
- This approach enhances the efficiency and practicality of trial management.
- The method is applicable to various clinical trial designs and data complexities.